Oxidative stress, inflammation and nutritional status during darbepoetin alpha treatment in peritoneal dialysis patients

Malgorzewicz, S.; Lichodziejewska-Niemierko, M.; Lizakowski, S.; Liberek, T.; Lysiak-Szydlowska, W.; Rutkowski, B.

Clinical Nephrology 73(3): 210-215

2010


ISSN/ISBN: 0301-0430
PMID: 20178720
Document Number: 644524
Recombinant human erythropoetin beta (rHuEPO) has not only an erythropoietic effect but also appears to affect production of cytokines and may improve nutritional status of dialysis patients. Darbepoetin alpha is a new erythropoiesis-stimulating protein with a threefold longer serum half-life when compared with rHuEPO.

Document emailed within 1 workday
Secure & encrypted payments